• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:吴浩,刘晓倩,朱日然.黄芩保肝活性成分及作用机制研究进展[J].药学研究,2025,44(8):786-792,832[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2395次   下载 758次 本文二维码信息
码上扫一扫!
黄芩保肝活性成分及作用机制研究进展
吴浩1,2,刘晓倩1,2,朱日然1,2
字体:加大+|默认|缩小-
(1.山东中医药大学附属医院药学部,山东 济南 250014;2.山东中医药大学第一临床医学院,山东 济南 250014)
摘要:
黄芩是一种常用的传统中药,具有清热燥湿,泻火解毒等功效。黄芩的主要活性成分涵盖了黄酮类、黄酮苷类、挥发油类、多糖类等化合物,其中尤以黄芩苷、汉黄芩苷为代表的黄酮苷类成分最为突出。目前,大量的科研工作者对黄芩在肝脏疾病治疗方面的作用进行了深入探究,研究发现黄芩中的黄酮类及黄酮苷类成分在治疗病毒性肝炎、酒精性肝病、非酒精性脂肪性肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)、肝硬化、肝癌(HCC)、药物性肝损伤等肝脏疾病具有较好的疗效。黄芩及其活性成分可有效降低肝损伤模型等动物血清转氨酶水平,减轻肝脏的病理学变化,缓解炎症反应严重程度,从而为肝脏的健康保驾护航。其作用机制较为复杂,主要涉及抗氧化、抗炎、抗纤维化、调节脂质代谢和免疫等方面。这些研究成果为黄芩在肝脏疾病的临床治疗中的应用提供了坚实的理论依据和广阔的前景。基于此,本文综合国内外文献,对黄芩保肝的活性成分及其可能的作用机制进行系统的整理,以期为黄芩在保肝方面临床应用和作为保肝药物的开发提供一定的参考。
关键词:  黄芩  保肝  活性成分  作用机制
DOI:10.13506/j.cnki.jpr.2025.08.010
基金项目:2023年全国中药特色技术传承人才培训项目(No.T20234832005);山东中医药学会临床药学科研专项基金项目(No.SDACM202204);山东省医药卫生科技项目(No.202313010888)
出版日期:2025-08-25
Research progress on the hepatoprotective active components and mechanisms of Scutellaria baicalensis
WU Hao1,2,LIU Xiaoqian1,2,ZHU Riran1,2
(1.Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China;2.The First Clinical Medical College,Shandong University of Traditional Chinese Medicine, Jinan 250014,China)
Abstract:
Scutellaria baicalensis, a widely utilized traditional Chinese medicine, is recognized for its properties in clearing heat and drying dampness, as well as eliminating fire and detoxifying the body. Its primary active constituents encompass flavonoids, flavonol glycosides, volatile oils, and polysaccharides, with flavonol glycosides, particularly baicalin and wogonoside, being the most significant. Extensive researches by numerous scientists have delved into the efficacy of Scutellaria baicalensis in addressing liver diseases. Studies indicate that the flavonoid and flavonol glycoside components within Scutellaria baicalensis exhibit notable therapeutic benefits in managing viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), cirrhosis, hepatocellular carcinoma (HCC), and drug-induced liver injury. These compounds effectively lower serum transaminase levels in animal models of liver injury, mitigate hepatic pathological alterations, and diminish the intensity of inflammatory reactions, thereby contributing to liver health preservation. The underlying mechanisms are multifaceted, primarily comprising anti-oxidative, anti-inflammatory, anti-fibrotic actions, as well as lipid metabolism modulation and immune regulation. Such research outcomes furnish a robust theoretical foundation and promising prospects for the clinical application of Scutellaria baicalensis in liver disease treatment. This paper aims to systematically review the active components of Scutellaria baicalensis along with their potential mechanisms in hepatic protection to provide valuable insights for clinical applications of Scutellaria baicalensis in hepatoprotection and the development of novel hepatoprotective agents.
Key words:  Scutellaria baicalensis  Hepatic protection  Active components  Action mechanisms
今日访问量:2644    总访问量:55339159
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司